10-Q: Antiaging Quantum Living Inc. Reports Increased Revenue but Widened Net Loss in Q3 2025

Sentiment:

Quarterly Report (Form 10-Q)


Antiaging Quantum Living Inc. reports a significant increase in revenue driven by online platform technical support, but also a widened net loss due to increased operating expenses for the quarter ended December 31, 2024.

Worse than expectedThe company's net loss increased significantly compared to the same period last year due to increased operating expenses.

Summary

  • Antiaging Quantum Living Inc. reported its financial results for the third quarter of fiscal year 2025, ended December 31, 2024.
  • The company's revenue increased significantly to $154,471, compared to $6,299 in the same period of the previous year.
  • However, the company's net loss also increased to $129,154, compared to a net loss of $97,090 in the same quarter of the previous year.
  • For the nine months ended December 31, 2024, revenue was $529,714 compared to $7,499 for the nine months ended December 31, 2023.
  • The net loss for the nine months ended December 31, 2024, was $540,808 compared to a net loss of $151,196 for the nine months ended December 31, 2023.
  • The company's increased revenue is attributed to its online platform technical operation support and maintenance services.
  • The increased net loss is primarily due to higher operating expenses related to business expansion, including increased rental expenses, employee wages, and start-up costs.
  • The company had an accumulated deficit of $1,230,111 as of December 31, 2024, and working capital of $293,921.
  • Management acknowledges conditions that raise substantial doubt about the company's ability to continue as a going concern and is implementing plans to improve profitability and secure additional funding.

Sentiment

Score: 4

Explanation: The document presents mixed signals. While revenue increased significantly, the widening net loss and going concern warning raise concerns. The sentiment is cautiously negative.

Positives

  • Significant increase in revenue driven by online platform technical operation support and maintenance services.
  • Conversion of short-term debt to long-term notes payable improves the company's financial structure.
  • The company received a renovation subsidy of $69,646 during the three months ended December 31, 2024, which was recognized as other income.
  • Working capital increased from a deficit of $647,227 as of March 31, 2024, to $293,921 as of December 31, 2024.

Negatives

  • Substantial increase in net loss due to rising operating expenses.
  • Accumulated deficit of $1,230,111 as of December 31, 2024.
  • Management acknowledges conditions that raise substantial doubt about the company's ability to continue as a going concern.
  • Material weaknesses in internal control over financial reporting related to US GAAP knowledge and segregation of duties.

Risks

  • The company's ability to continue as a going concern is uncertain due to negative financial trends.
  • Increased operating expenses may continue to impact profitability.
  • Material weaknesses in internal control over financial reporting could affect the accuracy and reliability of financial statements.
  • The company's reliance on shareholder loans and unrelated party loans for funding may pose a risk if these sources become unavailable.

Future Outlook

Management plans to improve business profitability, generate sufficient cash flow, and obtain additional working capital funds to address going concern issues.

Management Comments

  • Management is committed to implementing expense control measures in the near term to support liquidity.
  • Shareholders are prepared to provide additional funding as needed.

Industry Context

The company's shift towards healthcare management and insurance services reflects a broader trend in the industry towards integrated healthcare solutions and personalized medicine.

Comparison to Industry Standards

  • It is difficult to compare Antiaging Quantum Living Inc.'s results to industry standards due to its unique business model and early stage of development.
  • Comparable companies in the online advertising and health and beauty product sales industries may include companies like Amazon, Alibaba, and smaller niche e-commerce platforms.
  • However, the company's focus on technical operation support and maintenance services for online platforms differentiates it from traditional e-commerce businesses.
  • The company's financial performance should be benchmarked against similar companies in the healthcare management and insurance services sectors as it expands its operations in these areas.

Related Party Transactions

  • The company formalized an agreement with certain related parties, converting existing liabilities classified as Due to Related Parties in the amount of $ 841,959 into a promissory note with a maturity date of December 31, 2029.
  • During the nine months ended December 31, 2024, the Company did not repay or received advances from Mr. Wan, our President for working capital purpose.
  • During the nine months ended December 31, 2024, the Company borrowed funds from Tairan, an entity where Mr. Wans spouse is a shareholder, for working capital purpose.
  • During the nine months ended December 31, 2024, the Company borrowed funds from New Living, an entity where Mr. Wan is a controlling member, for working capital purpose.

Stakeholder Impact

  • Shareholders face increased risk due to the company's going concern issues and accumulated deficit.
  • Employees may be affected by potential cost-cutting measures.
  • Customers may experience disruptions if the company's financial stability is compromised.
  • Suppliers and creditors face increased risk of non-payment.

Next Steps

  • Management plans to improve business profitability.
  • Management plans to generate sufficient cash flow from operations.
  • Management plans to obtain additional working capital funds from the majority shareholder and President of the Company.
  • Management has begun a review to improve material weaknesses in internal control over financial reporting.

Key Dates

DateDescription
2008-01-01Effective date of PRC Enterprise Income Tax Law (EIT Law).
2014-12-29Antiaging Quantum Living Inc. was incorporated in New York.
2019-06-29Date of Stock Purchase Agreement between Lansdale Inc and Dazhong 368 Inc.
2019-07-01Transfer of 9,000,000 shares of Class A common stock to Dazhong 368 Inc., resulting in a change of control.
2019-08-01Loan from shareholders.
2023-03-28The Company amended its article with New York State to change the authorized common shares with a par value of $ 0.001 to 30,000,000 shares, no preferred shares.
2023-04-09Date of Stock Purchase Agreement by and among the parties thereto.
2023-04-10Mr. Barry Wan acquired control of 29,215,000 restricted shares of common stock.
2023-06-14The Company changed its name to Antiaging Quantum Living Inc.
2023-06-16Mr. Barry Wan consented to act as the new CEO and CFO after Ms. Jing Wan resigned.
2023-11-13Dao Ling Doctor Hangzhou Holding LTD was incorporated.
2023-11-30Dao Ling Doctor (Zhejiang) Health Management Limited was incorporated.
2023-12-06Dao Ling Doctor (Huzhou) Health Management Limited was incorporated.
2024-06-05The Company amended its article with New York State to increase the authorized shares of common stock of the Company from thirty million (30,000,000) shares of common stock, par value $ 0.001 per share, to six billion (6,000,000,000) shares of common stock, par value $ 0.00001 per share.
2024-07-25The Board of Directors of the Company approved the appointment of J&S Associate PLT to be the new independent registered public accounting firm for the financial period ending June 30, 2024.
2024-10-21Anti-Aging Care LLC was incorporated.
2024-12-31End of the reporting period for the financial results.
2025-02-19Date of the report, with 29,995,000 shares of Class A common stock outstanding.

Keywords

revenue, net loss, operating expenses, financial results, going concern, internal control, Antiaging Quantum Living, AAQL, financial statements

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.